Momentum Across Multiple Programs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Continued Strong Progress and Momentum Across Multiple Programs with Key Upcoming Data Milestones Beginning Q2 2023 STARS Phase 3 Program of Apraglutide in Short Bowel Syndrome with Intestinal. | April 19, 2023

United statesPatrick malloyAsahi kasei pharmaLuca santarelliProgram of apraglutideExchange commission onVectivbio holding ag nasdaqVectivbio holdingContinued strong progressMomentum across multiple programsShort bowel syndromeIntestinal failureComplete enrollmentAcute graft versus host diseaseRunway extends moreBeyond anticipated release